PRIVIA HEALTH GROUP INC (PRVA) Stock Price, Quote, News and Overview
NASDAQ:PRVA - Nasdaq - US74276R1023 - Common Stock - Currency: USD
PRVA Quote, Performance and Key Statistics
23.32
+0.42 (+1.83%)
The current stock price of PRVA is 23.32 USD. In the past month the price increased by 4.86%. In the past year, price increased by 24.44%.
PRVA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 12.12 | 90.75B | ||
| CVS | CVS HEALTH CORP | 10.61 | 85.16B | ||
| LH | LABCORP HOLDINGS INC | 16.81 | 20.73B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.36 | 19.87B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.91 | 15.02B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 118.65 | 12.88B | ||
| DVA | DAVITA INC | 14.86 | 10.85B | ||
| HIMS | HIMS & HERS HEALTH INC | 75.59 | 9.13B | ||
| CHE | CHEMED CORP | 24.41 | 8.42B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.80B | ||
| CRVL | CORVEL CORP | 26.8 | 5.75B | ||
| OPCH | OPTION CARE HEALTH INC | 24.23 | 5.40B |
Related stock screener links
About PRVA
Company Profile
Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,140 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The firm provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
Company Info
PRIVIA HEALTH GROUP INC
950 N. Glebe Rd., Suite 700
Arlington VIRGINIA US
CEO: Shawn Morris
Employees: 1102
Phone: 15713668850
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the stock price of PRIVIA HEALTH GROUP INC today?
The current stock price of PRVA is 23.32 USD. The price increased by 1.83% in the last trading session.
What is the ticker symbol for PRIVIA HEALTH GROUP INC stock?
The exchange symbol of PRIVIA HEALTH GROUP INC is PRVA and it is listed on the Nasdaq exchange.
On which exchange is PRVA stock listed?
PRVA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PRIVIA HEALTH GROUP INC stock?
28 analysts have analysed PRVA and the average price target is 30.21 USD. This implies a price increase of 29.55% is expected in the next year compared to the current price of 23.32. Check the PRIVIA HEALTH GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PRIVIA HEALTH GROUP INC worth?
PRIVIA HEALTH GROUP INC (PRVA) has a market capitalization of 2.83B USD. This makes PRVA a Mid Cap stock.
How many employees does PRIVIA HEALTH GROUP INC have?
PRIVIA HEALTH GROUP INC (PRVA) currently has 1102 employees.
What are the support and resistance levels for PRIVIA HEALTH GROUP INC (PRVA) stock?
PRIVIA HEALTH GROUP INC (PRVA) has a support level at 23.19 and a resistance level at 23.57. Check the full technical report for a detailed analysis of PRVA support and resistance levels.
Is PRIVIA HEALTH GROUP INC (PRVA) expected to grow?
The Revenue of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 10.88% in the next year. Check the estimates tab for more information on the PRVA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PRIVIA HEALTH GROUP INC (PRVA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PRVA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PRVA, evaluating the profitability, health, valuation and growth aspects
- PRIVIA HEALTH GROUP INC (PRVA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PRIVIA HEALTH GROUP INC (PRVA) Sales and EPS estimates to see what analysts future expectations are.
- PRIVIA HEALTH GROUP INC (PRVA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PRIVIA HEALTH GROUP INC (PRVA) Insider and Institutional Ownership to learn about the owners and their transactions.
- PRIVIA HEALTH GROUP INC (PRVA) Stock Chart to make your own analysis
- PRIVIA HEALTH GROUP INC (PRVA) Latest news and press-releases to stay up to date.
Does PRIVIA HEALTH GROUP INC (PRVA) stock pay dividends?
PRVA does not pay a dividend.
When does PRIVIA HEALTH GROUP INC (PRVA) report earnings?
PRIVIA HEALTH GROUP INC (PRVA) will report earnings on 2025-05-08, before the market open.
What is the Price/Earnings (PE) ratio of PRIVIA HEALTH GROUP INC (PRVA)?
The PE ratio for PRIVIA HEALTH GROUP INC (PRVA) is 212. This is based on the reported non-GAAP earnings per share of 0.11 and the current share price of 23.32 USD. Check the full fundamental report for a full analysis of the valuation metrics for PRVA.
What is the Short Interest ratio of PRIVIA HEALTH GROUP INC (PRVA) stock?
The outstanding short interest for PRIVIA HEALTH GROUP INC (PRVA) is 3.08% of its float. Check the ownership tab for more information on the PRVA short interest.
PRVA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PRVA. When comparing the yearly performance of all stocks, PRVA is one of the better performing stocks in the market, outperforming 86.52% of all stocks.
PRVA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to PRVA. While PRVA has a great health rating, there are worries on its profitability.
PRVA Financial Highlights
Over the last trailing twelve months PRVA reported a non-GAAP Earnings per Share(EPS) of 0.11. The EPS decreased by -42.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.83% | ||
| ROA | 1.27% | ||
| ROE | 2.26% | ||
| Debt/Equity | 0 |
PRVA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to PRVA. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 129.34% and a revenue growth 10.88% for PRVA